Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
171.8 EUR | -0.06% | +3.28% | +19.22% |
Jun. 11 | Merck KGaA to Build EUR62 Million Facility for Life Science Business | MT |
Jun. 07 | Health Care Up as Defensive Rotation Continues - Health Care Roundup | DJ |
Sales 2024 * | 21.32B 22.9B | Sales 2025 * | 22.64B 24.32B | Capitalization | 74.69B 80.22B |
---|---|---|---|---|---|
Net income 2024 * | 3B 3.22B | Net income 2025 * | 3.52B 3.78B | EV / Sales 2024 * | 3.79 x |
Net Debt 2024 * | 6.19B 6.65B | Net Debt 2025 * | 4.37B 4.69B | EV / Sales 2025 * | 3.49 x |
P/E ratio 2024 * |
25
x | P/E ratio 2025 * |
21.1
x | Employees | 62,345 |
Yield 2024 * |
1.35% | Yield 2025 * |
1.48% | Free-Float | 29.71% |
Latest transcript on Merck KGaA
1 day | -0.06% | ||
1 week | +2.60% | ||
Current month | +3.18% | ||
1 month | +10.48% | ||
3 months | +9.39% | ||
6 months | +20.99% | ||
Current year | +19.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 20-07-12 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 14-07-31 |
Director of Finance/CFO | 54 | 19-04-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 14-05-08 | |
Christian Raabe
BRD | Director/Board Member | - | - |
Chairman | 67 | 19-04-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.34% | 2 M€ | +13.56% | - | |
1.80% | 962 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 171.8 | -0.06% | 198,209 |
24-06-10 | 171.9 | +0.35% | 151,028 |
24-06-07 | 171.3 | -0.35% | 140,012 |
24-06-06 | 171.9 | +0.67% | 210,522 |
24-06-05 | 170.8 | +2.65% | 232,601 |
Delayed Quote Xetra, June 11, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.22% | 80.29B | |
+15.04% | 9.2B | |
-20.02% | 4.67B | |
+49.11% | 4.49B | |
+10.17% | 4.27B | |
+10.55% | 2.25B | |
-25.97% | 2.13B | |
+16.34% | 2.1B | |
-40.85% | 1.78B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- MRK Stock